The Head Adviser on Vaccines has Stock in the Company Charged with Making the Vaccine for UK

The Chief Scientific Adviser, who is leading the Government’s expert panel on vaccines, has 43,111 shares in GlaxoSmithKline (GSK) from his time as president of the drugs company. This is the company the UK government has contracted to make the vaccine. The Government has denied arguments that this is a potential conflict of interest, asserting that he is not involved in commercial decisions on coronavirus vaccines.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.